Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    xyrem
Show Display Options
Rank Status Study
1 Completed Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
Condition: Parkinson Disease
Intervention: Drug: sodium oxybate
2 Recruiting Xyrem and Brain Dopamine in Narcolepsy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
3 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
4 Unknown  Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease
Condition: Sleep-wake Disturbances in Motor-phase Parkinson`s Disease
Intervention: Drug: Sodium Oxybate
5 Completed
Has Results
Sodium Oxybate in Schizophrenia With Insomnia
Conditions: Schizophrenia;   Insomnia Related to Schizophrenia (307.42)
Intervention: Drug: Sodium Oxybate
6 Active, not recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
7 Terminated
Has Results
Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Placebo;   Drug: Sodium Oxybate
8 Withdrawn The Effect of Sodium Oxybate on Sleep Architecture
Condition: Mechanically Ventilated ICU Patients
Interventions: Drug: sodium oxybate;   Drug: placebo
9 Withdrawn Xyrem for Treatment Refractory Insomnia Due to PTSD
Conditions: PTSD;   Anxiety, Post Traumatic
Intervention: Drug: Xyrem
10 Completed A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Condition: Narcolepsy, Excessive Daytime Sleepiness
Interventions: Drug: Placebo;   Drug: Sodium Oxybate;   Drug: JZP-386
11 Completed Enhancing Slow Wave Sleep With Sodium Oxybate
Condition: Sleep
Intervention: Drug: sodium oxybate
12 Completed Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
Condition: Sleep Initiation and Maintenance Disorders
Interventions: Drug: zolpidem tartrate;   Drug: sodium oxybate;   Drug: Matching Placebos
13 Completed
Has Results
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
Condition: Fibromyalgia
Intervention: Drug: Xyrem®
14 Completed
Has Results
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Xyrem;   Drug: Xyrem Placebo;   Drug: Modafinil at established dose;   Drug: Modafinil (Placebo)
15 Completed
Has Results
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
Condition: Fibromyalgia
Interventions: Drug: Xyrem (sodium oxybate) oral solution;   Drug: Placebo
16 Unknown  Sodium Oxybate in Patients With Chronic Fatigue Syndrome.
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Sodium oxybate;   Drug: Placebo
17 Recruiting Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
Conditions: Spasmodic Dysphonia;   Voice Tremor
Intervention: Drug: Sodium oxybate
18 Not yet recruiting Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache
Condition: Cluster Headache
Interventions: Drug: Sodium Oxybate;   Drug: Placebo
19 Completed
Has Results
A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia
Condition: Fibromyalgia
Interventions: Drug: Xyrem®;   Drug: Placebo
20 Terminated Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients
Condition: Mild Alzheimer's Disease
Intervention: Drug: Sodium Oxybate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.